Neuroteg AI

Neuroteg AI is a biotechnology and healthcare startup founded in 2016 with a focus on using AI to detect neurodegenerative diseases earlier. Their slogan "AI could detect neurodegenerative diseases earlier with digital biomarkers tracking patients in a non-invasive way" encapsulates their mission. The company addresses the challenge of diagnosing Alzheimer's disease, which currently takes up to 2.5-3 years, often too late for effective intervention. They emphasize the potential of diagnosing the disease 5-10 years earlier to facilitate prevention and treatment. Neuroteg AI's approach involves digital biomarkers for non-invasive and cost-effective patient tracking, shifting away from the limited hospital-based brain scans. With no disclosed headquarters or last investment details, Neuroteg AI's innovative approach to tackling neurodegenerative diseases presents an exciting prospect for investors looking to tap into the biotechnology and healthcare industries.